教育经历 2011/09-2014/06，中国药科大学，药学院，博士 2008/09-2011/06，中国药科大学，药学院，硕士 2004/09-2008/07，中国药科大学，药学院，学士 工作经历 2018/07-至今， 中国药科大学，药学院，副教授 2016/01-2018/07，中国药科大学，药学院，特聘副研究员 2014/07-2016/01，中国药科大学，药学院，讲师 学术荣誉 2019/07，江苏省优秀青年科学基金获得者

(1) 智能药物递释系统研发及产业化 (2) 改良型新药研发及产业化

Du, J., Wang, C., Chen, Y., Zhong, L., Liu, X., Xue, L., Zhang, Y., Li, Y., Li, X., Tang, C., Su, Z.*, and Zhang, C*. Targeted downregulation of HIF-1alpha for restraining circulating tumor microemboli mediated metastasis. J Control Release. 2022; 343:457-468. (IF: 11.467) Li, X., Omonova Tuychi Qizi, C., Mohamed Khamis, A., Zhang, C. *, and Su, Z*. Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells. Pharm Res. 2022; 39:1065-1083. (IF: 4.580) Zhang, Y., Gong, F., Wu, Y., Hou, S., Xue, L., Su, Z.*, and Zhang, C*. Poly-beta-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis. Nano Lett. 2021; 21:9736-9745. (IF: 12.262) Zhang, L., Zhang, Y., Xue, Y., Wu, Y., Wang, Q., Xue, L., Su, Z.*, and Zhang, C*. Transforming Weakness into Strength: Photothermal-Therapy-Induced Inflammation Enhanced Cytopharmaceutical Chemotherapy as a Combination Anticancer Treatment. Adv Mater. 2019; 31:e1805936. (IF: 25.8) Wu, Y., Zhang, Y., Dai, L., Wang, Q., Xue, L., Su, Z.*, and Zhang, C. An apoptotic body-biomimic liposome in situ upregulates anti-inflammatory macrophages for stabilization of atherosclerotic plaques. J Control Release. 2019; 316:236-249. (IF: 7.9)